Synthesis of Novel Piperonal Derivatives and Evaluation of their Anticonvulsant Activity using A Nanoparticular Formulation

DOI:

https://doi.org/10.37285/ijpsn.2009.2.1.7

Authors

  • Jithan Aukunuru
  • Keerthana Eedula
  • Venkanna Pasham
  • Venumadhav Katla
  • Srinivas Reddy K

Abstract

Ancient Chinese medical literature and independent studies indicate that piperine possess anticonvulsant activity and demonstrates a high degree of safety. A similarity was also demonstrated with synthetic piperine derivatives as well. In this study, chalcones and Schiffs bases of piperonal with different any methyl ketones, and aromatic primary amines were synthesized using conventional and microwave-irradiation methods. Purification of these compounds was  effected by recrystallization from alcohol and characterized by NMR and IR spectra. The synthesized compounds were screened for their anticonvulsant activity using a 4-aminopyridine induced model with the help of a conventional and a current nanoparticular formulation approach. A drug delivery system methodology in the form of nanoparticles for screening was adopted because it has more advantages when compared to conventional formulations in drug discovery stages. Nanoparticle formulations encapsulating selected synthesized compounds were prepared using solvent evaporation technique by taking polycaprolactone as the polymer. Few piperonal synthesized derivatives demonstrated anticonvulsant activity which was lesser than the standard phenytoin. Unfortunately, nanoparticular formulations prepared in this current study encapsulating selected synthesized compounds did not show any activity, suggesting more work is needed to demonstrate positive results.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

piperonal derivatives, anticonvulsants, nanoparticles, screening, characterization, synthesis

Downloads

Published

2009-05-31

How to Cite

1.
Aukunuru J, Eedula K, Pasham V, Katla V, Reddy K S. Synthesis of Novel Piperonal Derivatives and Evaluation of their Anticonvulsant Activity using A Nanoparticular Formulation. Scopus Indexed [Internet]. 2009 May 31 [cited 2024 Dec. 23];2(1):435-42. Available from: https://ijpsnonline.com/index.php/ijpsn/article/view/285

Issue

Section

Research Articles

References

Aukunuru J. In the Era of Nanotechnology: Are Drug Delivery Systems Dawning a New Dress (Part I). Pharmabuzz. 2: 23-30 (2007).
Aukunuru JV, Ayalasomayajula SP and Kompella UB. Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells. J Pharm Pharmacol. 55: 1199-1206 (2003).
D'Hooge R, Pei YQ, Raes A, Lebrun P, van Bogaert PP and de Deyn PP. Anticonvulsant activity of piperine on seizures induced by excitatory amino acid receptor agonists. Arzneimittelforschung. 46: 557-560 (1996).
Echevarria A, Nascimento MD, Gerônimo V, Miller J and Giesbrecht A. NMR Spectroscopy, Hammett Correlations and Biological Activity of Some Schiff Bases Derived from Piperonal. J. Braz. Chem. Soc. 10: 60-64 (1999).
Koushik K, Dhanda DS, Cheruvu NP and Kompella UB. Pulmonary delivery of deslorelin: large-porous PLGA particles and HPbetaCD complexes. Pharm Res. 21: 1119-1126 (2004).
Mbuba CK, Ngugi AK, Newton CR and Carter JA. The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies. Epilepsia. 49: 1491-1503 (2008).
Mori A, Kabuto H and Pei YQ. Effects of piperine on convulsions and on brain serotonin and catecholamine levels in E1 mice. Neurochem Res. 10:1269-75 (1985).
Pal SK, Sharma K, Prabhakar S and Pathak A. Psychosocial, demographic and treatment seeking strategic behavious, including faith healing practices, among patients in northwest India. Epilepsy Behav. 13: 323-332 (2008).
Pavia DL, Lampman GM, Kriz GS and Engel RG. Introduction to organic laboratory techniques: a small-scale approach. 2nd ed. Brooks/Cole-Thomson Learning, Belmont (CA), 2005, pp 212.
Pei YQ, Yue W, Cui JR and Yao HY. A study of the central pharmacological action of piperine and its derivatives. Yao Xue Xue Bao. 15: 198-205 (1980).
Pei YQ. A review of pharmacology and clinical use of piperine and its derivatives. Epilepsia. 24: 177-182 (1983).
Pugh MJ, Van Cott AC, Cramer JA, Knoefel JE, Amuan ME, Tabares J, Ramsay RE and Berlowitz DR. Treatment In Geriatric Epilepsy Research (TIGER) team. Trends in antiepileptic drug prescribing for older patients with new-onset epilepsy: 2000-2004. Neurology. 70: 2171-2178 (2008).
Rao KS, Reddy MK, Horning JL and Labhasetwar V. TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs. Biomaterials. 29: 4429-4438 (2008).
Saishin Y, Silva RL, Saishin Y, Callahan K, Schoch C, Ahlheim M, Lai H, Kane F, Brazzell RK, Bodmer D and Campochiaro PA. Periocular injection of microspheres containing PKC412 inhibits choroidal neovascularization in a porcine model. Invest Ophthalmol Vis Sci. 44: 4989-4993 (2003).
Shankeshi J and Aukunuru J. Preparation, Characterization and Evaluation of Antidiabetic Activity of a Liposomal Formulation Encapsulating Curcumin, an Ayurvedic Natural Product. The Pharmacist. 3: 1-5 (2008).
Shankeshi J, Aukunuru J and Vanga MR. Preclinical Assessment of Sustained Release Biodegradable Curcumin Microspheres in Diabetes. Proc. A.P. Akademi of Sciences, Hyderabad. 11: 180-187 (2007).
Shulgin AT and Shulgin A. Phenethylamines I Have Known And Loved: A Chemical Love Story. Transform Press. Lafayette, California, 1991, pp100.